Live Clinical Telemetry & Global Regulatory Intelligence
Aggregating real-time data feeds from ClinicalTrials.gov, OpenFDA, and international regulatory bodies worldwide to scout, normalize, and revitalize stalled therapeutic candidates.
Live
450k+ Studies
Phase I/II Stalled
Worldwide Agencies
Stalled & Terminated Trial Radar
Direct API stream pulling recent non-active trials for secondary indication evaluation.
| NCT ID / Title | Sponsor | Conditions | Status | Action |
|---|---|---|---|---|
| Connecting to ClinicalTrials.gov REST API… | ||||
Global Regulatory Authority Integration Matrix
Comprehensive tracking across major international health authorities and oversight jurisdictions worldwide.
North America
Active Feed- US FDA (United States) OpenFDA / IND
- Health Canada (Canada) CTDB / DPD
Europe & United Kingdom
Active Feed- EMA / CTIS (European Union) CTR / EudraCT
- UK MHRA (United Kingdom) ILAP Pipeline
- Swissmedic (Switzerland) HPC / Authorizations
Asia-Pacific (APAC)
Active Feed- Japan PMDA (Japan) Sakigake / JAPIC
- China NMPA / CDE (China) CDE Registry
- Australia TGA (Australia) CTN / CTA Scheme
- South Korea MFDS (South Korea) K-FDA Approvals
- Singapore HSA (Singapore) TP Register
Latin America
Active Feed- ANVISA (Brazil) Sanitary Registry
- COFEPRIS (Mexico) Protocol Approvals
Africa & Middle East (Excluding Regional Restrictions)
Active Feed- Saudi SFDA (Saudi Arabia) Clinical Registry
- SAHPRA (South Africa) Reliance Pathways
- African Medicines Agency (AMA) / AVAREG Harmonized AU Network
How Eunoia Health Revitalizes IP
Converting unmined raw outputs into structured commercial clinical assets.
1. Automated Scouting
Continuous algorithms screen open databases and global regulatory registries for molecules with established Phase I safety profiles that lacked targeted secondary efficacy.
2. FAIR Normalization
Raw assay deposits and clinical logs are parsed and formatted into standard CDISC/SDTM schemas, ensuring complete data interoperability and audit readiness.
3. Matchmaking & CRO Trial
Repurposing dossiers are published to biopharma sponsors and research institutes to initiate accelerated, cost-effective Phase II proof-of-concept trials.
Deposit Dataset or Nominate Stalled IP
Submissions route directly to 02_Open_Data_Portal_Submissions Vault